<ul><li>Isomorphic Labs, an Alphabet spinout, has raised $600 million in funding for its AI drug design engine.</li><li>The funding round was led by Thrive Capital and joined by Alphabet and GV.</li><li>Isomorphic Labs' AI software streamlines the process of designing small molecules for therapeutic applications.</li><li>The funding will be used to enhance the software and support in-house drug development programs.</li></ul>

Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine

Discover more